Foghorn Therapeutics Inc. (FHTX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$30.9M

Net Income/Loss (FY2025)

-$74.3M

Total Assets (FY2025)

$198.1M

Total Equity (FY2025)

-$108.5M

Cash Flows from Operating Activities (FY2025)

-$86.1M

Source: Foghorn Therapeutics Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.